Fortress Biotech
FBIO
56 hedge funds and large institutions have $16.5M invested in Fortress Biotech in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 13 closing their positions.
78% more capital invested
Capital invested by funds: $9.23M → $16.5M (+$7.24M)
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
38% more call options, than puts
Call options by funds: $2.25M | Put options by funds: $1.64M
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
14% more funds holding
Funds holding: 49 → 56 (+7)
1.76% less ownership
Funds ownership: 16.78% → 15.01% (-1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$785K |
| 2 |
SC
Sculptor Capital
New York
|
+$528K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$322K |
| 4 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$304K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$246K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SF
Summit Financial
Parsippany,
New Jersey
|
-$1.44M |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$629K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$605K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$373K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$342K |
FBIO Hedge Fund Activity: Q3 2025 in Review
56 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2025, worth a combined $16.5M — up 78% from $9.23M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FBIO positions and 13 closed out — a net gain of 7 holders — while 15 added to existing stakes and 13 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $785K. The largest seller was Summit Financial, cutting an estimated $1.44M.
- 56 institutional investors held Fortress Biotech (FBIO) as of Q3 2025, up from 49 in Q2 2025.
- Funds reported $16.5M of Fortress Biotech stock for Q3 2025, up 78% quarter-over-quarter.
- 20 funds opened new Fortress Biotech positions in Q3 2025 and 13 closed out, a net change of +7 holders.
- The largest Fortress Biotech buyer in Q3 2025 was Susquehanna International Group, an estimated $785K added.
- The largest Fortress Biotech seller in Q3 2025 was Summit Financial, an estimated $1.44M sold.
Based on aggregated 13F filings for Q3 2025.